Two Blokes

Exelixis' Q2 Earnings: Will Cabometyx Sales Drive Growth?

  • click to rate
    Posted by Two Blokes Jul 23 - Filed in Stock - 11 views
    EXEL investors eye Cabometyx sales and zanzalintinib trial results ahead of Q2 earnings release on July 28.